Ledger.Open graph →
SEC Form D · Amendment · filed March 26, 2021

OncoNano Medicine, Inc

Offering
$60.0M
Sold
$26.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Southlake, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Martin Driscoll · Southlake, TXExec · DirectorMatthew Head · Southlake, TXExecJohn Dyett · Southlake, TXDirectorJoydeep Goswami · Southlake, TXDirectorAlvaro Guillem · Southlake, TXDirectorCaleb Smith · Southlake, TXDirectorNoel Ford · Dublin 2, IrelandDirectorTara Iii LLC · Santa Monica, CADirectorDavid B. Oglesby · London, United KingdomDirectorWalter J. Novicki · Fort Myers, FLDirectorBronwyn Wright · Dublin 2, IrelandExecAaron I. Payas · Queensway, J1Exec · DirectorAshish P. Sanghrajka · New York, NYDirectorEric W. Chan · San Francisco, CADirectorPaul J. Hopper · New York, NYExecJeffrey R. Bartfeld · San Francisco, CADirectorSherri S. Fleming · Grand Cayman, Cayman IslandsDirectorScott Conway · Incline Village, NVExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗